MAPT and Alzheimer disease: First, we tested whether either the level of local Aβ aggregates and/or the concentrations of soluble p-tau were most strongly associated with local increases in insoluble tau aggregates over time in early stages of AD using linear regression models in each of the 200 brain regions.